Tamoxifen: Teaching an old drug new tricks?

This publication has 20 references indexed in Scilit:

• A PIVOTAL ROLE FOR TGF‐β* IN ATHEROGENESIS?
  Biological Reviews, 1995
• Cardiac and vascular morbidity in women receiving adjuvant tamoxifen for breast cancer in a randomised trial
  BMJ, 1995
• Inactivation of the Type II TGF-β Receptor in Colon Cancer Cells with Microsatellite Instability
  Science, 1995
• Adjuvant Tamoxifen Therapy for Early Stage Breast Cancer and Second Primary Malignancies
  JNCI Journal of the National Cancer Institute, 1995
• Negative cross-talk between RelA and the glucocorticoid receptor: a possible mechanism for the antiinflammatory action of glucocorticoids
  Molecular Endocrinology, 1995
• Activation of transforming growth factor-β is inhibited in transgenic apolipoprotein(a) mice
  Nature, 1994
• Risk of endometrial cancer after tamoxifen treatment of breast cancer
  The Lancet, 1994
• Transcriptional interactions of transforming growth-factor-β with pro-inflammatory cytokines
  Current Biology, 1993
• Regulation of the levels of three transforming growth factor β mRNAs by estrogen and their effects on the proliferation of human breast cancer cells
  Molecular and Cellular Endocrinology, 1993
• Fatal myocardial infarction in the Scottish adjuvant tamoxifen trial. The Scottish Breast Cancer Committee.
  BMJ, 1991